PYXS
Pyxis Oncology Inc
3.40$
+2.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | – | – | 2.9% | 17.2% | |
| – | – | – | – | – | 97.1% | 82.8% | |
| – | – | – | – | – | 363.8% | 531.8% | |
| – | – | – | – | – | 157.4% | 160.2% | |
| – | – | – | – | – | 651.1% | 691.9% | |
| – | – | – | – | – | -554.1% | -609.2% | |
| – | – | – | – | – | -492.4% | -564.5% | |
| – | – | – | – | – | -13.4% | 10.0% | |
| – | – | – | – | – | -478.9% | -574.5% | |
| – | – | – | – | – | -405.8% | -532.0% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.